Bioavailability of arsenic in soil and house dust impacted by smelter activities following oral administration in cynomolgus monkeys

Toxicological Sciences

Volumn 28, Issue 2, 1995, Pages 215-222

  Freeman, G B ^a   Schoof, R A ^b   Ruby, M V ^b   Davis, A O ^a   Dill, J A ^c   Liao, S C ^b   Lapin, C A ^d   Bergstrom, P D ^d  

^a PTI Environmental Services ^*  (United States)

^b EXPONENT INC   (United States)

^c Northwest National Laboratory   (United States)

^d BP EXPLORATION   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOAVAILABILITY; CONTROLLED STUDY; FEMALE; HOUSE DUST; MONKEY; NONHUMAN; SMELTER; SOIL; TOXICOKINETICS; URINARY EXCRETION;

ADMINISTRATION, ORAL; ANIMALS; ARSENATES; ARSENIC; BIOLOGICAL AVAILABILITY; DUST; ENVIRONMENTAL POLLUTANTS; FECES; FEMALE; INJECTIONS, INTRAVENOUS; MACACA FASCICULARIS; METALLURGY; SOIL POLLUTANTS; URINE;

ANIMALIA; MACACA FASCICULARIS;

EID: 77957176260     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/28.2.215     Document Type: Article

References (22)

1. Buchet, J. P., Lauwerys, R., and Roels, H. (1981). Comparison of the urinary excretion of arsenic metabolites after a single oral dose of sodium arsenite, monomethyl arsonate or dimethyl arsinate in man. Int. Arch. Occup. Environ Health, 48, 71-79.
2. Chaney, R. L., Mielke, H. W., and Sterrett, S. B. (1989). Speciation, mobility, and bioavailability of soil lead. Environ. Geochem. Health 11(Suppl.), 105-129.
3. Chaney, R. L., and Ryan, J. A. (In Press). Risk based standards for arsenic, lead, and cadmium in urban soils. In Proceedings, Conference on Criteria for Decision Finding in Soil Protection: Evaluation of Arsenic, Lead, and Cadmium in Contaminated Urban Soils. October 9-11, 1991, Braunschweig, FRG.
4. Charbonneau, S. M., Spencer, K., Bryce, F., et al. (1978). Arsenic excretion by monkeys dosed with arsenic-containing fish or with inorganic arsenic. Bull. Environ. Contam. Toxicol. 20, 470-477.
5. Davies, B. E. (1974). Loss-on-ignition as an estimate of soil organic matter. Soil Sci. Soc. Am. Proc. 38, 150.
6. Davis, A., Ruby, M. V., and Bergstrom, P. D. (1992). Bioavailability of arsenic and lead in soils from the Butte, Montana, Mining District. Environ. Sci. Technol. 26(3), 461-468.
7. Davis, A., Drexler, J. W., Ruby, M. V., and Nicholson, A. (1993). Micromineralogy of mine wastes in relation to lead bioavailability, Butte, Montana. Environ. Sci. Technol. 27(7), 1415-1425.
8. Duggan, M. J., Inskip, M. J., Rundle, S. A., and Moorcroft, J. S. (1985). Lead in playground dust and on the hands of school children. Sci. Total Environ. 44, 65-79.
9. Freeman, G. B., Johnson, J. D., Killinger, J. M., Liao, S. C., Davis, A. O., Ruby, M. V., Chaney, R. L., Lovre, S. C., and Bergstrom, P. D. (1993). Bioavailability of arsenic in soil impacted by smelter activities following oral administration in rabbits. Fundam. Appl. Toxicol. 21, 83-88.
10. Groen, K., Vaessen, H. A. M. G., Kliest, J. J. G., Deboer, J. L. M., Van Ooik, T., Timmerman, A., and Vlug, R. G. (1993). Bioavailability of inorganic arsenic from bog ore-containing soil in the dog. Environ. Health Perspect. 102, 182-184.
11. Klein, R., and Hach, C. (1977). Standard additions, uses and limitations in spectrophotometric analysis. Am. Lab. 9, 21-30.
12. Marafante, E., and Vahter, M. (1987). Solubility, retention and metabolism of intratracheally and orally administered inorganic arsenic compounds in the hamster. Environ. Res. 42, 72-82.
13. McKinney, J. D. (1992). Metabolism and disposition of inorganic arsenic in laboratory animals and humans. Environ. Geochem. Health 14, 4348.
14. Tam, G. K., Charbonneau, S. M., Bryce, F., et al. (1979). Metabolism of inorganic arsenic (74As) in humans following oral ingestion. Toxicol. Appl. Pharmacol. 50, 319-322.
15. Tseng, W-P. (1977). Effects and dose-response relationships of skin cancer and blackfoot disease with arsenic. Environ. Health Perspect. 19, 109-119.
16. Tseng, W.-P., Chu, H.-M., How, S.-W., Fang, J.-M., Lin, C.-S., and Yen, S. (1968). Prevalence of skin cancer in an endemic area of chronic arse-nicism in Taiwan. J. Natl. Cancer Inst. 40, 453-463.
17. United States Environmental Protection Agency (U.S. EPA) (1983). Methods for Chemical Analysis of Water and Wastes. Publication Number EPA-600/4-79-020.
18. United States Environmental Protection Agency (U.S. EPA) (1986). Test Methods for Evaluating Solid Waste. SW 846, Office of Solid Waste and Emergency Response.
19. United States Environmental Protection Agency (U.S. EPA) (1989). Toxic Substances Control Act (TSCA), Good Laboratory Practice Standards: Final Rule. 40 CFR Part 792. Fed. Regist.
20. Vahter, M. (1981). Biotransformation of trivalent and pentavalent inorganic arsenic in mice and rats. Environ. Res. 25, 286-293.
21. Welling, P. G. (1989). Pharmacokinetics, American Chemical Society, Washington, DC.
22. Yamauchi, H., and Yamamura, Y. (1985). Metabolism and excretion of orally administered arsenic trioxide in the hamster. Toxicology 34, 113-121.